The Garvan-Weizmann Partnership

“The Garvan-Weizmann Collaboration is one of those rare opportunities where one plus one makes three”

Israel Bar-Joseph, Vice President, Weizmann Institute of Science

In 2016 the Weizmann Institute of Science and the Garvan Institute of Medical Research in Sydney, joined forces to combine the strengths of these two world-class research institutes in an organisations-wide collaboration.

The Garvan-Weizmann Partnership is particularly momentous as the Weizmann Institute is a global leader in multidisciplinary basic research and Garvan’s focus is on translational research. Together their complementary strengths enable scientists to answer some of science and medicine’s greatest questions faster than ever before in the areas of biomedical research, genomic medicine and genomic education.

The strategic direction of the partnership’s research is provided by a steering committee made up of senior scientific management from both Institutes. Currently underway, the Partnership has collaborative projects focussing on cancer (particularly breast cancer, melanoma, prostate cancer and multiple myeloma), on autoimmune diseases (including rheumatoid arthritis, lupus and multiple sclerosis to name a few, on cancer immunotherapies and personalised medicine for prediabetes.

Education is also a key part of the Partnership, with programs for scientific exchange between the Institutes and education for the greater community to advance the understanding of genomics through molecular visualisation and animation.

The Garvan-Weizmann Centre for Cellular Genomics is a seamlessly integrated one-stop shop, bringing together key intersecting technologies that make cellular genomics a reality

In August 2017 the Partnership was solidified with the construction and official opening of the Garvan-Weizmann Centre for Cellular Genomics, where the genetic makeup of thousands of individual cells can be studied at one time. Read our story about the official opening here.

Situated at the Garvan, the Centre is the only one of its kind in Australia, housing a range of new and cutting-edge technologies to study cells more closely than ever before. Here researchers are exploring thousands of individual cells simultaneously: uncovering each cell’s genomic sequence and its genetic output, understanding what makes it unique and exploring how it functions in health and disease.

Cellular genomics has only recently become feasible, uncovering thousands of pieces of information about each individual cell, instead of averaging information from a large group of cells (such as a tissue or a tumour biopsy). It therefore has extraordinary potential to revolutionise understanding of many diseases and develop personalised medicine approaches.

The Garvan-Weizmann Centre for Cellular Genomics is a seamlessly integrated one-stop shop, bringing together key intersecting technologies that make cellular genomics a reality. It’s only when these technologies and people are available under one roof that they can speed the process of biomedical research and use them to their best advantage.

The technology within the Garvan-Weizmann Centre for Cellular Genomics is cutting edge and is enabling researchers to enter uncharted territories in terms of what is possible, to unlock new understanding in cancer and other diseases that could lead to treatments.

The Centre’s construction was made possible through visionary philanthropic support from Mr John Roth and Ms Jillian Segal AM, Mr and Mrs Laurie and Di Sutton and The Johnny Kahlbetzer Family and a grant from the Government of New South Wales.  Read the our stories about the announcement and during construction.

Read the interview with the Centre’s CEO, Joseph Powell here
Watch the video: